period and were replaced with approved PSU awards. For the open performance period beginning in 2013, the initial target PSU awards terminated at the end of the
three-year
performance period and were settled after the performance period ended. There is no effect on recognition of compensation expense.
Other
—In addition to the above active programs, we have outstanding shares of restricted stock and RSUs that were either issued as part of our non-employee director compensation program for current and former members of the company’s Board of Directors or as part of an executive compensation program that has been discontinued or assumed as a result of an acquisition. Generally, the recipients of the restricted shares or units receive a dividend or dividend equivalent.
The following summarizes the aggregate activity of these restricted shares and units for the year ended December 31, 2024:
At December 31, 2024, all outstanding restricted stock and RSUs were fully vested and there was no remaining compensation cost to be recorded. The weighted-average grant date fair value of awards granted during 2023 and 2022 was $
115.88
and $
96.20
, respectively. The total fair value of awards issued during 2023 and 2022 was $
46
million and $
40
million, respectively.
Note 16—Income Taxes
Components of income tax provision (benefit) were:
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. Major components of deferred tax liabilities and assets at December 31 were:
At December 31, 2024, noncurrent assets and liabilities included deferred taxes of $
230
million and $
11,426
million, respectively. At December 31, 2023, noncurrent assets and liabilities included deferred taxes of $
255
million and $
8,813
million, respectively.
Our deferred tax liability increased during 2024 by $
2.5
billion due to the acquisition of Marathon Oil.
At December 31, 2024, the loss and credit carryforward deferred tax assets were primarily related to U.S. foreign tax credit carryforwards of $
3.3
billion and various jurisdictions net operating loss and credit carryforwards of $
1.6
billion. In 2024, $
1.2
billion of U.S. foreign tax credits expired. This reduction was partly offset by an increase of $
700
million in our U.S. net operating loss, foreign tax credit carryforwards, and other credit carryforwards due to our acquisition of Marathon Oil.
See Note
3
.
At December 31, 2023, the loss and credit carryforward deferred tax assets were primarily related to U.S. foreign tax credit carryforwards of $
4.7
billion and various jurisdictions net operating loss and credit carryforwards of $
0.9
billion.
The following table shows a reconciliation of the beginning and ending deferred tax asset valuation allowance for 2024, 2023 and 2022:
*Represents changes due to deferred tax assets that have no impact to our effective tax rate,